Short answer
iRhythm Holdings, Inc. (IRTC) filed an 8-K current report with the SEC on November 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q3 2026 financial results released for the quarter ended September 30, 2026.
iRhythm Holdings, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 2026 financial results released for the quarter ended September 30, 2026
- Exhibit 99.1 contains the press release with detailed results for investor review
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $221.6M, up 14.9%, with gross margin 74.2%, up 310 basis points, signaling strong Zio demand and operating efficiency
- Adjusted EBITDA $51.2M, margin 23.1%, versus $21.6M and 11.2% previously, showing substantial operating leverage
- GAAP net loss widened to $29.9M from $5.2M, driven partly by $49.8M of litigation settlements
- VitalConnect acquisition closed October 5, with approximately $16M expected 2026 revenue contribution and an FDA-cleared mobile cardiac telemetry offering
- 2026 guidance increased to $890M-$895M revenue and 15.5%-16.0% adjusted EBITDA margin, supported by growth and cost discipline
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other iRhythm Holdings, Inc. 8-K filings
Get the next IRTC 8-K as it lands
Follow IRTC for push alerts, or ask the research agent what this filing means.